To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
European Medicines Agency
Monday 16th October 2017

Asked by: Mary Creagh (Labour - Coventry East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what preparations his Department has made to replicate the relevant functions of the European Medicines Agency after the UK leaves the EU.

Answered by Steve Brine

Our overall aim in the negotiations is to ensure that patients in the United Kingdom and across the European Union continue to be able to access the best and most innovative medicines while being assured that their safety is protected. We are committed to continue a close working relationship with the European Medicines Agency (EMA), and the exact nature of this relationship will be determined through our negotiations.

The UK already has substantial capacity and expertise to regulate and evaluate the safety of our medicines. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) directly assesses the vast majority of medicines used by patients within the UK. The MHRA is globally recognised for its expertise and they typically undertake between 20 – 35% of the EMA’s licensing and vigilance work, including a significant proportion of pharmacovigilance work and safety referrals.


Written Question
European Medicines Agency
Monday 16th October 2017

Asked by: Mary Creagh (Labour - Coventry East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment his Department has made of the number of staff required to replicate the relevant functions of the European Medicines Agency after the UK leaves the EU.

Answered by Steve Brine

Our overall aim in the negotiations is to ensure that patients in the United Kingdom and across the European Union continue to be able to access the best and most innovative medicines while being assured that their safety is protected. We are committed to continue a close working relationship with the European Medicines Agency (EMA), and the exact nature of this relationship will be determined through our negotiations.

The UK already has substantial capacity and expertise to regulate and evaluate the safety of our medicines. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) directly assesses the vast majority of medicines used by patients within the UK. The MHRA is globally recognised for its expertise and they typically undertake between 20 – 35% of the EMA’s licensing and vigilance work, including a significant proportion of pharmacovigilance work and safety referrals.


Written Question
European Centre for Disease Prevention and Control
Friday 13th October 2017

Asked by: Mary Creagh (Labour - Coventry East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment his Department has made of the cost to the public purse of replicating the relevant functions of the European Centre for Disease Prevention and Control after the UK leaves the EU.

Answered by Steve Brine

As part of the negotiations, Public Health England is examining the European Union security measures we are currently part of, including alternative health security arrangements. We are seeking a strategic partnership to continue close working relationship with our European partners. However, whilst negotiations are ongoing, we are not in a position to speculate on the cost to the public purse and the number of staff required to replicate the relevant functions of the European Centre for Disease Prevention and Control.

The United Kingdom is a world leader in tackling serious cross-border threats to health and has a well-developed health protection system highly regarded by European partners. We use and benefit from a range of international information-sharing tools in the area of health security, which are by no means limited to EU mechanisms but include other channels such as the 2005 International Health Regulations.

In addition, the UK already has good collaborative relationship with other international partners such as the World Health Organization. It is in everyone’s interests to continue to collaborate closely, and to maintain access to our intelligence, risk assessment, guidance and management advice.


Written Question
European Centre for Disease Prevention and Control
Friday 13th October 2017

Asked by: Mary Creagh (Labour - Coventry East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment his Department has made of the number of staff required to replicate the relevant functions of the European Centre for Disease Prevention and Control after the UK leaves the EU.

Answered by Steve Brine

As part of the negotiations, Public Health England is examining the European Union security measures we are currently part of, including alternative health security arrangements. We are seeking a strategic partnership to continue close working relationship with our European partners. However, whilst negotiations are ongoing, we are not in a position to speculate on the cost to the public purse and the number of staff required to replicate the relevant functions of the European Centre for Disease Prevention and Control.

The United Kingdom is a world leader in tackling serious cross-border threats to health and has a well-developed health protection system highly regarded by European partners. We use and benefit from a range of international information-sharing tools in the area of health security, which are by no means limited to EU mechanisms but include other channels such as the 2005 International Health Regulations.

In addition, the UK already has good collaborative relationship with other international partners such as the World Health Organization. It is in everyone’s interests to continue to collaborate closely, and to maintain access to our intelligence, risk assessment, guidance and management advice.


Written Question
European Centre for Disease Prevention and Control
Friday 13th October 2017

Asked by: Mary Creagh (Labour - Coventry East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what preparations his Department has made to replicate the relevant functions of the European Centre for Disease Prevention and Control after the UK leaves the EU.

Answered by Steve Brine

As part of the negotiations, Public Health England is examining the European Union security measures we are currently part of, including alternative health security arrangements. We are seeking a strategic partnership to continue close working relationship with our European partners. However, whilst negotiations are ongoing, we are not in a position to speculate on the cost to the public purse and the number of staff required to replicate the relevant functions of the European Centre for Disease Prevention and Control.

The United Kingdom is a world leader in tackling serious cross-border threats to health and has a well-developed health protection system highly regarded by European partners. We use and benefit from a range of international information-sharing tools in the area of health security, which are by no means limited to EU mechanisms but include other channels such as the 2005 International Health Regulations.

In addition, the UK already has good collaborative relationship with other international partners such as the World Health Organization. It is in everyone’s interests to continue to collaborate closely, and to maintain access to our intelligence, risk assessment, guidance and management advice.


Written Question
European Food Safety Authority
Thursday 12th October 2017

Asked by: Mary Creagh (Labour - Coventry East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what preparations his Department has made to replicate the relevant functions of the European Food Safety Authority after the UK leaves the EU.

Answered by Steve Brine

Departments are currently working together to understand the impacts that withdrawal from the European Union will have across a number of sectors and cross-cutting areas, including the European Food Safety Authority. The European Food Safety Authority provides independent scientific advice and risk assessments covering a wide range of policy areas. Options for the future of risk assessment and scientific advice in the United Kingdom are being developed by the Government including understanding any cost and staffing implications. Requirements will depend on the nature of the relationship the UK has with the European Food Safety Authority once the UK leaves the EU. It will be our priority to maintain the UK’s high standards of food and feed safety, and to ensure we take a risk-based, proportionate approach when providing risk assessments.


Written Question
European Food Safety Authority
Thursday 12th October 2017

Asked by: Mary Creagh (Labour - Coventry East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment he has made of the cost to the public purse of replicating the relevant functions of the European Food Safety Authority after the UK leaves the EU.

Answered by Steve Brine

Departments are currently working together to understand the impacts that withdrawal from the European Union will have across a number of sectors and cross-cutting areas, including the European Food Safety Authority. The European Food Safety Authority provides independent scientific advice and risk assessments covering a wide range of policy areas. Options for the future of risk assessment and scientific advice in the United Kingdom are being developed by the Government including understanding any cost and staffing implications. Requirements will depend on the nature of the relationship the UK has with the European Food Safety Authority once the UK leaves the EU. It will be our priority to maintain the UK’s high standards of food and feed safety, and to ensure we take a risk-based, proportionate approach when providing risk assessments.


Written Question
European Food Safety Authority
Thursday 12th October 2017

Asked by: Mary Creagh (Labour - Coventry East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment his Department has made of the number of staff required to replicate the relevant functions of the European Food Safety Authority after the UK leaves the EU.

Answered by Steve Brine

Departments are currently working together to understand the impacts that withdrawal from the European Union will have across a number of sectors and cross-cutting areas, including the European Food Safety Authority. The European Food Safety Authority provides independent scientific advice and risk assessments covering a wide range of policy areas. Options for the future of risk assessment and scientific advice in the United Kingdom are being developed by the Government including understanding any cost and staffing implications. Requirements will depend on the nature of the relationship the UK has with the European Food Safety Authority once the UK leaves the EU. It will be our priority to maintain the UK’s high standards of food and feed safety, and to ensure we take a risk-based, proportionate approach when providing risk assessments.


Speech in Commons Chamber - Mon 27 Feb 2017
Health and Social Care

"The hon. Lady is making some excellent points. The sustainability and transformation plan for West Yorkshire will take around £1.1 billion out of our health system over the next four years—£700 million from the NHS and £400 million from social care services—as a result of which centres such as the …..."
Mary Creagh - View Speech

View all Mary Creagh (Lab - Coventry East) contributions to the debate on: Health and Social Care

Speech in Commons Chamber - Thu 26 Jan 2017
Breast Cancer Drugs

"I congratulate my hon. Friend on securing this debate. She certainly makes a powerful speech on behalf of her friend. Does she agree that when NICE looks at the cost-value ratio, stories such as that of her friend, who kept eight people in work, should also be a factor? We …..."
Mary Creagh - View Speech

View all Mary Creagh (Lab - Coventry East) contributions to the debate on: Breast Cancer Drugs